282 related articles for article (PubMed ID: 17511372)
1. The human papilloma virus, the vaccines, and oral and oropharyngeal squamous cell carcinoma: what every dentist should know.
Closmann JJ
Gen Dent; 2007; 55(3):252-4; quiz 255, 264. PubMed ID: 17511372
[TBL] [Abstract][Full Text] [Related]
2. Risk factors in oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden.
Rosenquist K
Swed Dent J Suppl; 2005; (179):1-66. PubMed ID: 16335030
[TBL] [Abstract][Full Text] [Related]
3. Oral HPV: the need for patient education.
Merchant VA
J Mich Dent Assoc; 2012 Mar; 94(3):16, 83. PubMed ID: 22662379
[No Abstract] [Full Text] [Related]
4. Vaccine may decrease chances of oral cancer.
Br Dent J; 2007 Sep; 203(6):299. PubMed ID: 17891076
[No Abstract] [Full Text] [Related]
5. Oncogenic impact of human papilloma virus in head and neck cancer.
Heffernan CB; O'Neill JP; Timon C
J Laryngol Otol; 2010 Sep; 124(9):941-4. PubMed ID: 20519038
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus vaccines.
Satyaprakash A; Creed R; Ravanfar P; Mendoza N
Dermatol Ther; 2009; 22(2):150-7. PubMed ID: 19335726
[TBL] [Abstract][Full Text] [Related]
7. The GARDASIL vaccine can prevent cervical carcinoma caused by human papilloma virus (HPV) (results from our participation and from the study carried out in Greece).
Ansstasiou-Fotaki P; Deligeoroglou E; Kreatsas G
Akush Ginekol (Sofiia); 2007; 46(3):17-20. PubMed ID: 18018777
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus (HPV) vaccines: limited cross-protection against additional HPV types.
Herrero R
J Infect Dis; 2009 Apr; 199(7):919-22. PubMed ID: 19236278
[No Abstract] [Full Text] [Related]
9. Quadrivalent human papillomavirus vaccine.
Barr E; Tamms G
Clin Infect Dis; 2007 Sep; 45(5):609-7. PubMed ID: 17682997
[TBL] [Abstract][Full Text] [Related]
10. Prevention strategies against the human papillomavirus: the effectiveness of vaccination.
Stanley M
Gynecol Oncol; 2007 Nov; 107(2 Suppl 1):S19-23. PubMed ID: 17938013
[TBL] [Abstract][Full Text] [Related]
11. Cervical cancer prevention in the human papilloma virus vaccine era.
Ghazal-Aswad S
Ann N Y Acad Sci; 2008 Sep; 1138():253-6. PubMed ID: 18837904
[TBL] [Abstract][Full Text] [Related]
12. Squamous cell carcinoma of the oropharynx in Australian males induced by human papillomavirus vaccine targets.
Hong AM; Grulich AE; Jones D; Lee CS; Garland SM; Dobbins TA; Clark JR; Harnett GB; Milross CG; O'Brien CJ; Rose BR
Vaccine; 2010 Apr; 28(19):3269-72. PubMed ID: 20226244
[TBL] [Abstract][Full Text] [Related]
13. The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years.
Brown DR; Kjaer SK; Sigurdsson K; Iversen OE; Hernandez-Avila M; Wheeler CM; Perez G; Koutsky LA; Tay EH; Garcia P; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Steben M; Bosch FX; Dillner J; Joura EA; Kurman RJ; Majewski S; Muñoz N; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan J; Lupinacci LC; Giacoletti KE; Sings HL; James M; Hesley TM; Barr E
J Infect Dis; 2009 Apr; 199(7):926-35. PubMed ID: 19236279
[TBL] [Abstract][Full Text] [Related]
14. Chapter 16: HPV vaccines in immunocompromised women and men.
Palefsky JM; Gillison ML; Strickler HD
Vaccine; 2006 Aug; 24 Suppl 3():S3/140-6. PubMed ID: 16950001
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
[TBL] [Abstract][Full Text] [Related]
16. [Human papilloma virus infection and cervical cancer: a public health perspective].
Torres-Poveda KJ; Burguete A; Bermúdez-Morales VH; Madrid-Marina V
Rev Invest Clin; 2008; 60(5):414-20. PubMed ID: 19227439
[No Abstract] [Full Text] [Related]
17. Cost-utility analysis of vaccination against HPV in Israel.
Ginsberg GM; Fisher M; Ben-Shahar I; Bornstein J
Vaccine; 2007 Sep; 25(37-38):6677-91. PubMed ID: 17706844
[TBL] [Abstract][Full Text] [Related]
18. HPV-linked oral cancer: another argument for universal HPV vaccination of boys and girls.
Laurence J
AIDS Read; 2008 Jul; 18(7):345-6. PubMed ID: 18655309
[No Abstract] [Full Text] [Related]
19. Recurrence in patients with oral and oropharyngeal squamous cell carcinoma: human papillomavirus and other risk factors.
Rosenquist K; Wennerberg J; Annertz K; Schildt EB; Hansson BG; Bladström A; Andersson G
Acta Otolaryngol; 2007 Sep; 127(9):980-7. PubMed ID: 17712679
[TBL] [Abstract][Full Text] [Related]
20. Reducing patient risk for human papillomavirus infection and cervical cancer.
Herbert J; Coffin J
J Am Osteopath Assoc; 2008 Feb; 108(2):65-70. PubMed ID: 18303060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
